Skip to main content
logo
Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.514
+0.064 (4.38%)
At close: May 8, 2026, 4:00 PM EDT
1.410
-0.104 (-6.84%)
Pre-market: May 11, 2026, 5:52 AM EDT

Company Description

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure.

The company is based in Ras al-Khaimah, the United Arab Emirates. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals US logo
CountryUnited Arab Emirates
Founded2020
IPO DateMay 9, 2025
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
CEOVinod Menon

Contact Details

Address:
B4-204A5, Business Centre 04, RAKEZ Business Zone-FZ
Ras al-Khaimah
United Arab Emirates
Websitemindwavedao.com

Stock Details

Ticker SymbolAPUS
ExchangeNYSEAMERICAN
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$4.00
CIK Code1894525
CUSIP Number03771D102
ISIN NumberUS03771D1028
Employer ID85-1099700
SIC Code2834

Key Executives

NamePosition
Dr. Vinod MenonFounder, Chief Executive Officer and Director
Erik C. EmersonPresident
Erick J. FrimChief Financial Officer
Dr. Christopher M. H. Kim M.D.Chief Medical Officer
Captain Sandeep Singh YadavChief Operating Officer
Amardeep SinghChief Technology Officer

Latest SEC Filings

DateTypeTitle
May 7, 2026SCHEDULE 13D/AFiling
May 5, 20268-KCurrent Report
May 4, 202610-KAnnual Report
May 4, 20268-KCurrent Report
Apr 22, 20268-KCurrent Report
Apr 16, 20268-KCurrent Report
Apr 9, 2026425Filing
Apr 9, 20268-K/A[Amend] Current report
Mar 31, 2026NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Mar 30, 2026SCHEDULE 13D/AFiling
View All SEC Filings